To include your compound in the COVID-19 Resource Center, submit it here.

Eureka Therapeutics, Memorial Sloan Kettering, Juno Therapeutics deal

Memorial Sloan and Eureka granted Juno exclusive, worldwide rights to binding domains

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE